AbbVie Partners with Chicago Cubs on "Striking Out Cancer"

Core Points - AbbVie has launched a multi-year partnership with the Chicago Cubs to support cancer advocacy through the "Striking Out Cancer" campaign, which begins with the Cubs' game against the Cincinnati Reds [1][3] - For every strikeout by a Cubs pitcher at home during the 2025 regular season, AbbVie will donate $233, reflecting the statistic of approximately 233 Americans diagnosed with cancer every hour [1][2] - The funds raised will be donated to Cubs Charities, benefiting non-profit organizations like Conquer Cancer®, which focuses on advancing cancer research and patient care [1][3][7] Company Overview - AbbVie is a global biopharmaceutical company dedicated to discovering and delivering transformative medicines across various therapeutic areas, including oncology [2][4] - The company aims to address serious health issues and improve patient outcomes through innovative therapies for cancers such as leukemias, lymphomas, and lung cancer [2][4] Partner Overview - The Chicago Cubs, a historic Major League Baseball franchise, have a commitment to community engagement and charitable initiatives, including the "Striking Out Cancer" campaign [5][6] - Cubs Charities has invested over $51 million in community programs since 2009, focusing on youth development and safe play environments [6] Beneficiary Overview - Conquer Cancer®, the ASCO Foundation, has awarded over $203 million in grants to improve cancer care and research since its inception in 1984 [7]